
Sreenivasan Padmanabhan
Supervisory Patent Examiner (ID: 11184, Phone: (571)272-0629 , Office: P/1627 )
| Most Active Art Unit | 1621 |
| Art Unit(s) | 1621, 1617, 1204, 1627 |
| Total Applications | 773 |
| Issued Applications | 622 |
| Pending Applications | 48 |
| Abandoned Applications | 103 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 12057062
[patent_doc_number] => 20170333407
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-11-23
[patent_title] => 'METHOD FOR TREATING UNDERACTIVE BLADDER SYNDROME'
[patent_app_type] => utility
[patent_app_number] => 15/524000
[patent_app_country] => US
[patent_app_date] => 2015-10-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11064
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15524000
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/524000 | METHOD FOR TREATING UNDERACTIVE BLADDER SYNDROME | Oct 29, 2015 | Abandoned |
Array
(
[id] => 12022161
[patent_doc_number] => 20170312260
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-11-02
[patent_title] => 'NEW INDICATION OF AZELNIDIPINE PHARMACEUTICAL COMPOSITION FOR TREATING CANCER'
[patent_app_type] => utility
[patent_app_number] => 15/521500
[patent_app_country] => US
[patent_app_date] => 2015-10-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 3333
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15521500
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/521500 | NEW INDICATION OF AZELNIDIPINE PHARMACEUTICAL COMPOSITION FOR TREATING CANCER | Oct 22, 2015 | Abandoned |
Array
(
[id] => 10669673
[patent_doc_number] => 20160015818
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-01-21
[patent_title] => 'COMPOSITIONS AND METHODS FOR PHYSIOLOGICAL DELIVERY USING CANNABIDIOL'
[patent_app_type] => utility
[patent_app_number] => 14/804125
[patent_app_country] => US
[patent_app_date] => 2015-07-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 2527
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14804125
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/804125 | COMPOSITIONS AND METHODS FOR PHYSIOLOGICAL DELIVERY USING CANNABIDIOL | Jul 19, 2015 | Abandoned |
Array
(
[id] => 10365750
[patent_doc_number] => 20150250756
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-09-10
[patent_title] => 'METHODS OF TREATING HYPERCHOLESTEROLEMIA'
[patent_app_type] => utility
[patent_app_number] => 14/718986
[patent_app_country] => US
[patent_app_date] => 2015-05-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11551
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14718986
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/718986 | METHODS OF TREATING HYPERCHOLESTEROLEMIA | May 20, 2015 | Abandoned |
Array
(
[id] => 11689558
[patent_doc_number] => 20170165274
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-06-15
[patent_title] => 'COMPOSITION'
[patent_app_type] => utility
[patent_app_number] => 15/125228
[patent_app_country] => US
[patent_app_date] => 2015-03-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9808
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15125228
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/125228 | COMPOSITION | Mar 10, 2015 | Abandoned |
Array
(
[id] => 9932252
[patent_doc_number] => 20150080444
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-03-19
[patent_title] => 'METHOD OF TREATING BENDAMUSTINE-RESPONSIVE CONDITIONS IN PATIENTS REQUIRING REDUCED VOLUMES FOR ADMINISTRATION'
[patent_app_type] => utility
[patent_app_number] => 14/554269
[patent_app_country] => US
[patent_app_date] => 2014-11-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4265
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14554269
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/554269 | METHOD OF TREATING BENDAMUSTINE-RESPONSIVE CONDITIONS IN PATIENTS REQUIRING REDUCED VOLUMES FOR ADMINISTRATION | Nov 25, 2014 | Abandoned |
Array
(
[id] => 9135698
[patent_doc_number] => 20130296413
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-11-07
[patent_title] => 'N-DESMETHYL-DOXEPIN AND METHODS OF USING THE SAME TO TREAT SLEEP DISORDERS'
[patent_app_type] => utility
[patent_app_number] => 13/933975
[patent_app_country] => US
[patent_app_date] => 2013-07-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9659
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13933975
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/933975 | N-DESMETHYL-DOXEPIN AND METHODS OF USING THE SAME TO TREAT SLEEP DISORDERS | Jul 1, 2013 | Abandoned |
Array
(
[id] => 10267104
[patent_doc_number] => 20150152101
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-06-04
[patent_title] => 'ACTIVE COMPOUNDS FOR COMBATING GREASY SKIN'
[patent_app_type] => utility
[patent_app_number] => 14/405969
[patent_app_country] => US
[patent_app_date] => 2013-06-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 8695
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14405969
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/405969 | ACTIVE COMPOUNDS FOR COMBATING GREASY SKIN | Jun 4, 2013 | Abandoned |
Array
(
[id] => 9175061
[patent_doc_number] => 20130317046
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-11-28
[patent_title] => 'USE OF A DPP-4 INHIBITOR IN AUTOIMMUNE DIABETES, PARTICULARLY LADA'
[patent_app_type] => utility
[patent_app_number] => 13/898966
[patent_app_country] => US
[patent_app_date] => 2013-05-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20553
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13898966
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/898966 | USE OF A DPP-4 INHIBITOR IN AUTOIMMUNE DIABETES, PARTICULARLY LADA | May 20, 2013 | Abandoned |
Array
(
[id] => 9269759
[patent_doc_number] => 20140024677
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-01-23
[patent_title] => 'METHODS FOR INDUCING MITOCHONDRIAL BIOGENESIS'
[patent_app_type] => utility
[patent_app_number] => 13/859546
[patent_app_country] => US
[patent_app_date] => 2013-04-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 20041
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13859546
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/859546 | METHODS FOR INDUCING MITOCHONDRIAL BIOGENESIS | Apr 8, 2013 | Abandoned |
Array
(
[id] => 9771089
[patent_doc_number] => 20140294753
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-10-02
[patent_title] => 'NOVEL USE OF GANODERMIC ACIDS FOR TREATING CANCER'
[patent_app_type] => utility
[patent_app_number] => 13/854024
[patent_app_country] => US
[patent_app_date] => 2013-03-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 5366
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13854024
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/854024 | NOVEL USE OF GANODERMIC ACIDS FOR TREATING CANCER | Mar 28, 2013 | Abandoned |
Array
(
[id] => 8618228
[patent_doc_number] => 20130023540
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-01-24
[patent_title] => 'TREATMENT OF MASTITIS'
[patent_app_type] => utility
[patent_app_number] => 13/624179
[patent_app_country] => US
[patent_app_date] => 2012-09-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2053
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13624179
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/624179 | TREATMENT OF MASTITIS | Sep 20, 2012 | Abandoned |
Array
(
[id] => 9512014
[patent_doc_number] => 20140148507
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-05-29
[patent_title] => 'PHARMACEUTICAL COMPOSITION AND SOLID GALENIC FORM HAVING A HIGH DRONEDARONE CONTENT, AND METHOD FOR PREPARING SAME'
[patent_app_type] => utility
[patent_app_number] => 14/131310
[patent_app_country] => US
[patent_app_date] => 2012-07-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5662
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14131310
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/131310 | PHARMACEUTICAL COMPOSITION AND SOLID GALENIC FORM HAVING A HIGH DRONEDARONE CONTENT, AND METHOD FOR PREPARING SAME | Jul 5, 2012 | Abandoned |
Array
(
[id] => 8382316
[patent_doc_number] => 20120225938
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-09-06
[patent_title] => 'METHOD FOR TREATING CENTRAL NERVOUS SYSTEM DISORDERS'
[patent_app_type] => utility
[patent_app_number] => 13/470377
[patent_app_country] => US
[patent_app_date] => 2012-05-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 10934
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13470377
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/470377 | METHOD FOR TREATING CENTRAL NERVOUS SYSTEM DISORDERS | May 13, 2012 | Abandoned |
Array
(
[id] => 9198888
[patent_doc_number] => 20130338203
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-12-19
[patent_title] => 'TREATMENT OF ARTERIAL AGEING BY COMBINATION OF RAAS INHIBITOR AND HMG-CoA REDUCTASE INHIBITOR'
[patent_app_type] => utility
[patent_app_number] => 14/001816
[patent_app_country] => US
[patent_app_date] => 2012-02-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 25121
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14001816
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/001816 | TREATMENT OF ARTERIAL AGEING BY COMBINATION OF RAAS INHIBITOR AND HMG-CoA REDUCTASE INHIBITOR | Feb 27, 2012 | Abandoned |
Array
(
[id] => 8227246
[patent_doc_number] => 20120141454
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-06-07
[patent_title] => 'Methods of Use of Inhibitors of Phosphodiesterases and Modulators of Nitric Oxide, Reactive Oxygen Species, and Metalloproteinases in the Treatment of Peyronie\'s Disease, Arteriosclerosis and Other Fibrotic Diseases'
[patent_app_type] => utility
[patent_app_number] => 13/372094
[patent_app_country] => US
[patent_app_date] => 2012-02-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 21
[patent_no_of_words] => 38851
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13372094
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/372094 | Methods of Use of Inhibitors of Phosphodiesterases and Modulators of Nitric Oxide, Reactive Oxygen Species, and Metalloproteinases in the Treatment of Peyronie's Disease, Arteriosclerosis and Other Fibrotic Diseases | Feb 12, 2012 | Abandoned |
Array
(
[id] => 9331159
[patent_doc_number] => 20140057941
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-02-27
[patent_title] => 'Methods For Increasing Mean Corpuscular Volume'
[patent_app_type] => utility
[patent_app_number] => 13/977992
[patent_app_country] => US
[patent_app_date] => 2012-01-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 5916
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13977992
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/977992 | Methods For Increasing Mean Corpuscular Volume | Jan 12, 2012 | Abandoned |
Array
(
[id] => 9122062
[patent_doc_number] => 20130288984
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-10-31
[patent_title] => 'COMBINATION'
[patent_app_type] => utility
[patent_app_number] => 13/978765
[patent_app_country] => US
[patent_app_date] => 2012-01-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 11009
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13978765
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/978765 | COMBINATION | Jan 10, 2012 | Abandoned |
| 13/337614 | SILICONE-BASED COMPOSITION FOR SKIN TREATMENT | Dec 26, 2011 | Abandoned |
Array
(
[id] => 7784805
[patent_doc_number] => 20120046361
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-02-23
[patent_title] => 'ETHYL PYRUVATE COMPOSITIONS AND METHODS'
[patent_app_type] => utility
[patent_app_number] => 13/214016
[patent_app_country] => US
[patent_app_date] => 2011-08-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3203
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0046/20120046361.pdf
[firstpage_image] =>[orig_patent_app_number] => 13214016
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/214016 | ETHYL PYRUVATE COMPOSITIONS AND METHODS | Aug 18, 2011 | Abandoned |